Clinical Trials Browser

Phase 2/3 × Breast Neoplasms × Granulocyte Colony-Stimulating Factor × Clear all

NCT00169104 2018-07-20

Effects of Granulocyte Colony-stimulating Factor (G-CSF), Trastuzumab, and Vinorelbine on Immune Cell Function

Phase 2/3 Terminated

23 enrolled 10 charts

Breast Neoplasms